Hormonal function of the fetoplacental complex in pregnant women with low-lying chorion





hormones, placental dysfunction, low-lying chorion, trophoblast


Purpose - to analyze the hormonal function of the fetoplacental complex in pregnant women with normal and low-lying chorion.

Materials and methods. 50 pregnant women with a low-lying chorion (main group) and 50 pregnant women with a position of the chorion in the body and fundus of the uterus (control group) were involved in the laboratory examination. All examined women of the main group were divided into 2 subgroups, depending on the period of gestation (25 women at 5-8 weeks of gestation and 25 women at 9-12 weeks of gestation). According to these terms, the control group was also divided (25 women at 5-8 weeks of gestation and 25 women at 9-12 weeks of gestation). During pregnancy in the І trimester of pregnancy, the content of hormones in blood serum was determined: estradiol, chorionic gonadotropin, placental lactogen, progesterone.

Results. Conducted research on the level of hormones in the blood serum of pregnant women showed that the concentration of estradiol in the main group was reduced throughout the І trimester of pregnancy. In particular, the content of this hormone was lower compared to the control by 7.2% in 5-8 weeks of gestation (p˃0.05), and by 23.9% - in 9-12 weeks (p<0.05). The content of progesterone in pregnant women with low-lying chorion, on average, was lower compared to the control group by 10.9% in the period of 5-8 weeks of pregnancy (p<0.05) and by 21.0% in the period of 9-12 weeks (p<0.05). It was also established that the level of placental lactogen in the blood serum of pregnant women at 9-12 weeks of gestation in the main group was probably lower compared to the control (p<0.05). Analyzing the content of chorionic gonadotropin, it is noted its significant decrease during the entire early period of gestation in the main group compared to the control, respectively: at 5-8 weeks of gestation - 36990.0±210.0 mg/l and 43270.0±226.0 ml/l (p<0.05); at 9-12 weeks - 37194.0±395.0 mg/l and 54700.55±525.0 ml/l (р<0.05).

Conclusions. Pregnant women with low-lying chorion in the early stages of gestation had a much slower increase in hormone levels and lag in quantitative indicators was observed compared to pregnant women in which the chorion was located in the fundus and body of the uterus. This is evidence of hormonal dysfunction of the placenta, and therefore, a marker of the developing of placental dysfunction. A decrease in the levels of hormones of the fetoplacental complex in pregnant women with low placentation is manifested by clinical signs of early placental dysfunction in the form of a threat of termination of pregnancy, partial detachment of the chorion in the early term, spontaneous miscarriage and lead to further progression of placental dysfunction.

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethic Committee of Bukovinian State Medical University. The informed consent of the patients was obtained for the conducting the studies.

No conflict of interests was declared by the authors.


Bai J, Qi QR, Li Y et al. (2020). Estrogen receptors and estrogen-induced uterine vasodilation in pregnancy. Int J Mol Sci. 21 (12): 43-49. https://doi.org/10.3390/ijms21124349; PMid:32570961 PMCid:PMC7352873

Baschat AA, Cosmi E, Bilardo CM et al. (2007). Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol. 109 (2;1): 253-261. https://doi.org/10.1097/01.AOG.0000253215.79121.75; PMid:17267821

Costa MA. (2016). The endocrine function of human placenta: an overview. Reprod Biomed Online. 32 (1): 14-43. https://doi.org/10.1016/j.rbmo.2015.10.005; PMid:26615903

Fournier T. (2016). Human chorionic gonadotropin: Different glycoforms and biological activity depending on its source of production. Ann Endocrinol. 77 (2): 75-81. https://doi.org/10.1016/j.ando.2016.04.012; PMid:27177499

Halasz M, Szekeres-Bartho J. (2013). The role of progesterone in implantation and trophoblast invasion. J Reprod Immunol. 97 (1): 43-50. https://doi.org/10.1016/j.jri.2012.10.011; PMid:23432871

Hough A, Chandra SB. (2019). Normal Placental Development and the Triad of Placental Dysfunction: The Maternal and Fetal Complications. J Contemp Med. 9 (2): 183-190. https://doi.org/10.16899/jcm.562662

Hunt K, Kennedy SH, Vatish M. (2016). Definitions and reporting of placental insufficiency in biomedical journals: a review of the literature. Eur J Obstet Gynecol Reprod Biol. 205:146-149. https://doi.org/10.1016/j.ejogrb.2016.08.029; PMid:27591716

Jansen CHJR, Kastelein AW, Kleinrouweler CE et al. (2020). Development of placental abnormalities in location and anatomy. Acta Obstet Gynecol Scand. 99 (8): 983-993. https://doi.org/10.1111/aogs.13834; PMid:32108320 PMCid:PMC7496588

Jansen CHJR, Kleinrouweler CE, Leeuwen L et al. (2019). Final outcome of a second trimester low-positioned placenta: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 240: 197-204. https://doi.org/10.1016/j.ejogrb.2019.06.020; PMid:31323500

Ku CW, Zhang X, Zhang VRY et al. (2021). Gestational age-specific normative values and determinants of serum progesterone through the first trimester of pregnancy. Scientific Reports. 11: 41-61. https://doi.org/10.1038/s41598-021-83805-w; PMid:33603122 PMCid:PMC7893162

Lazurenko VV, Borzenko IB, Lyashchenko OA et al. (2021). Modern diagnosis of placental dysfunction and its complications. Inter Collegas. 8 (3): 182-187. https://doi.org/10.35339/ic.8.3.182-187

Lee CL, Chiu PCN, Hautala L et al. (2013). Human chorionic gonadotropin and its free β-subunit stimulate trophoblast invasion independent of LH/hCG receptor. Mol Cell Endocrinol. 375 (1-2): 43-52. https://doi.org/10.1016/j.mce.2013.05.009; PMid:23684886

Robinson DP, Klein SL. (2012). Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav. 62 (3): 263-271. https://doi.org/10.1016/j.yhbeh.2012.02.023; PMid:22406114 PMCid:PMC3376705

Schock H, Zeleniuch-Jacquotte A, Lundin E et al. (2016). Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study. BMC Pregnancy and Childbirth. 16: 146. https://doi.org/10.1186/s12884-016-0937-5; PMid:27377060 PMCid:PMC4932669

Sibiak R, Jankowski M, Gutaj P, Mozdziak PE. (2020). Placental Lactogen as a Marker of Maternal Obesity, Diabetes, and Fetal Growth Abnormalities: Current Knowledge and Clinical Perspectives. J Clin Medic. 9 (4): 1142. https://doi.org/10.3390/jcm9041142; PMid:32316284 PMCid:PMC7230810

Sood R, Arora P, Cheema HK, Nagpal M. (2019). Outcome of Abnormal Placental Attachments in Pregnancies with a Review of Literature. Curr Trends Diagn Treat. 3 (1): 1-7. https://doi.org/10.5005/jp-journals-10055-0057

Taylor T, Quinton A, Hyett J. (2017). The developmental origins of placental function. Austral J Ultras Medic. 20 (4): 141-146. https://doi.org/10.1002/ajum.12071; PMid:34760487 PMCid:PMC8409859

Varas-Godoy M, Monteiro LJ, Correa P et al. (2016). Addition of human placental lactogen cell free fetal rna as a marker of placental dysfunction may improves prediction of preeclampsia during first trimester: Risk factors, prediction of preeclampsia. Pregn Hypert: An Intern J Women's Cardiovasc Health. 6 (3): 167. https://doi.org/10.1016/j.preghy.2016.08.064

Vdovichenko JP, Kuritsina SA, Ursaki NO. (2014). Diagnostics and preventive maintenance of perinatal pathologies at abnormal placentation. Health of woman. 2: 157-158.

Wan J, Hu Z, Zeng K et al. (2018). The reduction in circulating levels of estrogen and progesterone in women with preeclampsia. Pregnancy Hypertens. 11: 18-25. https://doi.org/10.1016/j.preghy.2017.12.003; PMid:29523268

Zavlanos A, Tsakiridis I, Chatzikalogiannis I et al. (2021). Early- and Late-onset Intrauterine Growth Retardation. Donald School J Ultrasound Obstet Gynecol. 15 (1): 97-108. https://doi.org/10.5005/jp-journals-10009-1686